Purpose Oral warfarin anticoagulation is a long-term treatment that is required after heart
valve replacement. This treatment can prevent serious complications, such as embolism …

Atrial fibrillation (AF) and coronary artery disease (CAD) often coexist. Both conditions confer
an increased risk of acute thrombotic complications. However, the pathogenesis of thrombus …

Warfarin is clinically used as the first choice for long-term anticoagulant therapy, and for the
prevention of thromboembolic events. However, when used at low doses in the long term or …

Pradaxa is a novel oral anticoagulant, which was originally used to prevent thrombosis
following joint replacement surgery. The aim of the current study was to investigate the effect …

Stroke prevention is the main priority in the management cascade of atrial fibrillation. Most
patients require long-term oral anticoagulation (OAC) and may require percutaneous …

Abstract Acute Venous Thromboembolism (VTE) is a common disease associated with the
significant morbidity and mortality. We reviewed clinical outcomes systematically with …

Introduction: Oral anticoagulation is central to the management of patients with atrial
fibrillation (AF) and at least one additional stroke risk factor. For decades, the vitamin K …

Introdução: Fibrilação atrial (FA) é a taquiarritmia supraventricular mais frequente e que
implica em grandes gastos em saúde e aumenta morbimortalidade dos pacientes, além de …

Background: Atrial Fibrillation (AF) is a common abnormal heart rhythm, responsible for high
rate of cardiovascular and cerebrovascular morbidity and mortality. The prevalence of AF in …

Introduction Oral anticoagulation is central to the management of patients with atrial
fibrillation (AF) and at least one additional stroke risk factor. For decades, the vitamin K …